Search the Newsreel

Bikaji Foods Q1 profit rises to ₹645M; earnings call held on Aug 6

Rail Vikas Nigam to host Q1 FY27 earnings call on Aug 13

Earnings call transcript: Playtika Q2 2026 revenue beats as stock falls 14%

Playtika (PLTK) reported second-quarter 2026 revenue of $731.1 million, exceeding analyst forecasts, and saw a significant improvement in adjusted EBITDA margin due to reduced marketing spend and increased direct-to-consumer sales. Despite the revenue beat, the stock fell 13.88% as management indicated that full-year guidance …

Playtika (NASDAQ:PLTK) Shares Gap Down on Disappointing Earnings

Playtika (PLTK) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2026, Playtika Holding (PLTK) reported revenue of $731.1 million, up 5% over the same period last year. EPS came in at $0.15, compared to $0.02 in the year-ago quarter. The reported revenue represents a surprise of +2.48% over the …

Playtika Holding (PLTK) Q2 Earnings Match Estimates

Playtika Holding (PLTK) reported Q2 earnings of $0.15 per share, matching the Zacks Consensus Estimate and showing an increase from $0.02 per share a year ago. The mobile game developer's revenues of $731.1 million also surpassed estimates. The stock currently holds a Zacks Rank …

Anika Therapeutics (ANIK) Insider Gary Fischetti Buys 2,000 Shares, Increasing Stake to 54,015 Shares

Gary Fischetti, a Director at Anika Therapeutics Inc (ANIK), recently purchased 2,000 shares at $20.53 each, increasing his total holdings to 54,015 shares. This transaction, valued at approximately $41,060, follows a trend of insider buying at the company, with 3 insider buys and no …

Anika Therapeutics (NASDAQ:ANIK) Director Purchases 1,000 Shares

Anika Therapeutics Director Gary Fischetti purchased 1,000 shares of ANIK stock for $20.75 each, increasing his direct ownership to 53,015 shares. This transaction follows strong quarterly earnings where Anika reported $0.42 EPS and $32.61 million in revenue, both exceeding analyst expectations. Despite institutional investors …

Playtika (NASDAQ: PLTK) grows Q2 2026 profit and EBITDA

Playtika Holding Corp. reported its Q2 2026 financial results, showing revenue of $731.1 million, a 5.0% increase year over year, and Adjusted EBITDA of $206.1 million, up 23.4% year over year. Despite a sequential decrease in revenue, the company achieved significant growth in net …

Playtika misses Q2 earnings despite revenue beat

Playtika Holding Corp. (NASDAQ:PLTK) reported second-quarter earnings that missed analyst expectations, with an adjusted EPS of $0.13 against a consensus of $0.22. Despite the earnings miss, the mobile gaming company's revenue of $731.1 million surpassed estimates and increased 5.0% year-over-year. Playtika reaffirmed its full-year …

Earnings Flash (PLTK) Playtika Holding Corp. Reports Q2 Revenue $731.1M, vs. FactSet Est of $713.1M

Playtika Holding Corp. reported Q2 revenue of $731.1 million, surpassing FactSet's estimate of $713.1 million. This financial announcement was published on August 6, 2026, at 06:58 am EDT. The company, a mobile gaming entertainment and technology firm, will also hold an earnings release for …

Stock awards for CMO Korczak at Playtika Holding Corp. (PLTK)

Playtika Holding Corp. (PLTK) Chief Marketing Officer Nir Korczak received 64,154 restricted stock units (RSUs) and 128,308 performance stock units (PSUs) on August 4, 2026. The RSUs will vest quarterly over approximately three years, while the PSUs have a three-year performance period with vesting …

Earnings call transcript: Bikaji Foods Q1 2026 stock falls as growth mix improves

Bikaji Foods International consolidated net profit rises 0.40% in the June 2026 quarter

PLTK|Playtika Holding Corp|Price:2.800|Chg%:-0.140

Playtika earnings missed by $0.09, revenue topped estimates

Stock Alert: Aurobindo Pharma, PB Fintech, Biocon, Bikaji Foods Intl, JK Lakshmi Cement

Playtika Holding Corp. (NASDAQ:PLTK) Given Consensus Recommendation of "Hold" by Brokerages

Playtika Holding Corp. (NASDAQ:PLTK) has received a consensus "Hold" recommendation from seven brokerages, with an average 12-month price target of $4.17, slightly above its current price of $3.89. Analyst actions were mixed, including a reaffirmed buy rating from TD Cowen and neutral ratings with …

Playtika Holding Corp. Reports Q2 2026 Financial Results

Playtika Holding Corp. announced its financial results for Q2 2026, reporting revenue of $731.1 million, a 5.0% increase year-over-year, and Adjusted EBITDA of $206.1 million, up 23.4% year-over-year. The company reaffirmed its full-year 2026 guidance, expecting results towards the lower end of the projected …

Playtika Holding Corp. (PLTK) CEO awarded 1,122,694 RSUs and new PSUs

Playtika Holding Corp. (PLTK) CEO Robert Antokol was granted 1,122,694 Restricted Stock Units (RSUs) and 2,245,389 Performance Stock Units (PSUs) on August 4, 2026. The RSUs vest quarterly over three years, while the PSUs have a three-year performance period with vesting tied to total …

Playtika Holding Corp. (PLTK) grants RSUs and PSUs to legal officer

Playtika Holding Corp. (PLTK) has granted its Chief Legal Officer, Michael Daniel Cohen, 160,385 restricted stock units (RSUs) and 320,770 performance stock units (PSUs) on August 4, 2026. The RSUs will vest quarterly over three years, while the PSUs have a three-year performance period, …

Bikaji Foods revenue rises 12.5% to ₹7,343 mn as margins expand

Playtika earnings in focus as strategic review continues

Playtika Holding Corp. is expected to report its second-quarter earnings, with analysts anticipating a return to profitability at 17 cents per share on $713.2 million in revenue. Investors will be closely watching for sustained growth in its direct-to-consumer channels and any updates regarding the …

Is Playtika (PLTK) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, perhaps …

Kritika Wires Q1 Results: Net profit up 16% YoY to ₹1.60 crore

Bikaji Foods Reports Standalone Q1 Net Profit Of ₹64.5 Crore, Approves ₹15 Crore Nepal JV

Q1 Results: Power Grid, Cummins India, Aurobindo Pharma, PB Fintech, Biocon, Berger Paints, Bikaji Foods, others to post earnings on August 5

Anika Therapeutics Lifts Outlook After Margin Surge

Anika Therapeutics reported strong Q2 earnings, with record commercial and international revenue and significantly improved gross margins and adjusted EBITDA. The company raised its full-year guidance for revenue growth and adjusted EBITDA margin, despite acknowledging regulatory uncertainties for some products and potential quarterly variability …

Playtika Holding Corp expected to post earnings of 17 cents a share - Earnings Preview

Playtika Holding Corp (PLTK) is expected to announce earnings of 17 cents per share. This information is provided as an earnings preview from Refinitiv, suggesting upcoming financial results for the company.

Q1 2025 Anika Therapeutics Inc Earnings Call Transcript

Anika Therapeutics Inc. (ANIK) reported mixed results for Q1 2025, with commercial channel revenue up 18% and regenerative solutions growing 33%, driven by the Integrity implant system. Strategic initiatives and cost-saving measures proved effective, with anticipated US approvals for Halofast and Singal expected to …

Price to earnings forward of Radhika Jeweltech Ltd – NSE:RADHIKAJWE

Kritika Wires confirms no fund raising activity in Q1FY26

Playtika's Debt, Slower Growth Weigh on Outlook as Q2 Seen Matching Estimates, Wedbush Says

Playtika Holding (PLTK) is expected to post Q2 results that broadly match consensus, with margin imp PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

Price to sales forward of Zuleika Gold Limited – ASX:ZAG

Perceptive Advisors LLC Sells 3,106,568 Shares of Inhibikase Therapeutics, Inc. $IKT

Perceptive Advisors LLC significantly reduced its stake in Inhibikase Therapeutics (NASDAQ:IKT) by selling over 3.1 million shares, though other institutional investors like Sands Capital Alternatives and ADAR1 Capital Management increased their holdings. Despite this sale, analyst sentiment remains largely positive with an average "Buy" …

Anika Therapeutics (ANIK) Stock Fair Value Rises After Q2 Beat And Higher Guidance